AI-generated summary
This Cochrane review pooled 32 randomized controlled trials with 2,640 immunocompetent participants to assess interventions for preventing cold sores. The authors report that long-term oral antiviral use reduced recurrence, though the clinical benefit was small, while topical antivirals and most other interventions showed no clear efficacy. Evidence quality was mostly low to moderate.
- Participants
- 2,640
- Studies included
- 32
- Who or what was studied
- Immunocompetent people of all ages with herpes simplex labialis (cold sores)
- Limits stated in the abstract
- The authors state that evidence quality was low to moderate for most outcomes and very low for a few, with inconsistent results across doses and small individual trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Randomized controlled trial, Risk of bias, Low-level laser therapy, Confidence interval, Ultraviolet, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.